INDIVIDUAL-DIFFERENCES IN DISPOSITION OF DRUGS METABOLIZED IN BODY

被引:42
作者
ALVAN, G
机构
关键词
D O I
10.2165/00003088-197803020-00005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:155 / 175
页数:21
相关论文
共 115 条
[1]   KINETICS OF RIFAMPICIN AND ISONIAZID ADMINISTERED ALONE AND IN COMBINATION TO NORMAL SUBJECTS AND PATIENTS WITH LIVER-DISEASE [J].
ACOCELLA, G ;
BONOLLO, L ;
TENCONI, LT ;
GARIMOLDI, M ;
MAINARDI, M ;
NICOLIS, FB .
GUT, 1972, 13 (01) :47-+
[2]   INDIVIDUAL DIFFERENCES IN PHARMACOKINETICS OF MONOMETHYLATED TRICYCLIC ANTIDEPRESSANTS - ROLE OF GENETIC AND ENVIRONMENTAL FACTORS AND CLINICAL IMPORTANCE [J].
ALEXANDERSON, B ;
SJOQVIST, F .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :739-+
[4]   URINARY-EXCRETION OF NORTRIPTYLINE AND 5 OF ITS METABOLITES IN MAN AFTER SINGLE AND MULTIPLE ORAL DOSES [J].
ALEXANDERSON, B ;
BORGA, O .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 5 (03) :174-180
[6]   AVAILABILITY OF ORALLY ADMINISTERED NORTRIPTYLINE [J].
ALEXANDERSON, B ;
BORGA, O ;
ALVAN, G .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 5 (03) :181-185
[7]   PREDICTION OF STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE FROM SINGLE ORAL DOSE KINETICS - STUDY IN TWINS [J].
ALEXANDERSON, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 6 (01) :44-53
[8]  
ALEXANDERSON B, 1972, THESIS LINKOPING U
[9]  
ALVAN G, 1975, CLIN PHARMACOL THER, V18, P364
[10]   IMPORTANCE OF 1ST-PASS ELIMINATION FOR INTERINDIVIDUAL DIFFERENCES IN STEADY-STATE CONCENTRATIONS OF ADRENERGIC BETA-RECEPTOR ANTAGONIST ALPRENOLOL [J].
ALVAN, G ;
LIND, M ;
MELLSTROM, B ;
VONBAHR, C .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1977, 5 (03) :193-205